title: NTPDase and 5'-nucleotidase activities in physiological and disease conditions: new perspectives for human health.
abstract: Extracellular nucleotides and nucleosides act as signaling molecules involved in a wide spectrum of biological effects. Their levels are controlled by a complex cell surface-located group of enzymes called ectonucleotidases. There are four major families of ectonucleotidases, nucleoside triphosphate diphosphohydrolases (NTPDases/CD39), ectonucleotide pyrophosphatase/phosphodiesterases (E-NPPs), alkaline phosphatases and ecto-5'-nucleotidase. In the last few years, substantial progress has been made toward the molecular identification of members of the ectonucleotidase families and their enzyme structures and functions. In this review, there is an emphasis on the involvement of NTPDase and 5'-nucleotidase activities in disease processes in several tissues and cell types. Brief background information is given about the general characteristics of these enzymes, followed by a discussion of their roles in thromboregulatory events in diabetes, hypertension, hypercholesterolemia and cancer, as well as in pathological conditions where platelets are less responsive, such as in chronic renal failure. In addition, immunomodulation and cell-cell interactions involving these enzymes are considered, as well as ATP and ADP hydrolysis under different clinical conditions related with alterations in the immune system, such as acute lymphoblastic leukemia (ALL), B-chronic lymphocytic leukemia (B-CLL) and infections associated with human immunodeficiency virus (HIV). Finally, changes in ATP, ADP and AMP hydrolysis induced by inborn errors of metabolism, seizures and epilepsy are discussed in order to highlight the importance of these enzymes in the control of neuronal activity in pathological conditions. Despite advances made toward understanding the molecular structure of ectonucleotidases, much more investigation will be necessary to entirely grasp their role in physiological and pathological conditions.
authors.affiliation: Laboratório de Enzimologia Toxicológica, Departamento de Química, CCNE, Universidade Federal de Santa Maria, Avenida Roraima, no 1000, Cidade Universitária, Bairro Camobi, Santa Maria-RS, 97105-900, Brazil. mariaschetinger@gmail.com
authors.forename: Maria Rosa C
authors.initials: MR
authors.lastname: Schetinger
authors.forename: Vera Maria
authors.initials: VM
authors.lastname: Morsch
authors.forename: Carla Denise
authors.initials: CD
authors.lastname: Bonan
authors.forename: Angela T S
authors.initials: AT
authors.lastname: Wyse
mesh_terms: D015720:5'-Nucleotidase / Q000502:physiology*; D000241:Adenosine / Q000502:physiology; D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D015703:Antigens, CD / Q000494:pharmacology / Q000502:physiology*; D001081:Apyrase / Q000494:pharmacology / Q000502:physiology*; D050197:Atherosclerosis / Q000097:blood / Q000201:enzymology; D001777:Blood Coagulation / Q000502:physiology*; D001792:Blood Platelets / Q000502:physiology; D002450:Cell Communication / Q000502:physiology; D003711:Demyelinating Diseases / Q000201:enzymology; D004827:Epilepsy / Q000201:enzymology; D006801:Humans; D008661:Metabolism, Inborn Errors / Q000201:enzymology / Q000503:physiopathology; D009203:Myocardial Infarction / Q000097:blood / Q000201:enzymology; D009369:Neoplasms / Q000178:diet therapy / Q000201:enzymology; D015539:Platelet Activation / Q000502:physiology; D010974:Platelet Aggregation / Q000187:drug effects; D012640:Seizures / Q000201:enzymology; D015398:Signal Transduction; D013629:Tamoxifen / Q000627:therapeutic use; D013927:Thrombosis / Q000503:physiopathology
chemical_list: D015703:Antigens, CD; D013629:Tamoxifen; D000255:Adenosine Triphosphate; D015720:5'-Nucleotidase; D001081:Apyrase; C067869:CD39 antigen; D000241:Adenosine